All In Biotech

Drug Trial Radar · NCT01975064

Cancer and Anesthesia: Survival After Radical Surgery - a Comparison Between Propofol or Sevoflurane Anesthesia

A Randomized, Open-label Study to Compare Propofol Anesthesia With Sevoflurane Anesthesia in Terms of Overall Survival in Patients With Surgical Intervention for Either Breast-, Colon- or Rectal Cancer

Last checked: Nov 19, 2026Latest source record: Dec 14, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 5,774 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

5,774

Actual

Start

Nov 2013

Primary completion

Aug 31, 2022

Study completion Aug 31, 2022

Sponsor

Lead sponsor
Uppsala UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Region Örebro County; University Hospital, Linkoeping; Lund University Hospital; Kalmar County Hospital; Skellefteå lasarett; Wroclaw Medical University; Sundsvall Hospital; Peking University First Hospital; Helsingborgs Hospital; Air Force Military Medical University, China; RenJi Hospital; Uppsala University Hospital; University Hospital Sestre Milosrdnice; Växjö Hospital
First posted
Nov 4, 2013

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Single (participant)
Primary purpose
Supportive care
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine whether anesthesia maintained with propofol results in better one- and five-year-survival than anesthesia maintained with sevoflurane.

Conditions

  • Breast Neoplasms
  • Colonic Neoplasms
  • Rectal Neoplasms

Interventions

  • PropofolDrug

    Propofol will be infused individually for a sufficient level of anesthesia during the entire surgical procedure.

  • SevofluraneDrug

    Sevoflurane will be administered by vaporizer individually for a sufficient level of anesthesia during the entire surgical procedure.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Over all survivalTime frame: Five years

Locations

15 sites in 3 countries. Site status is shown where the registry gives one.

  • Peking University First Teaching Hospital

    Beijing, China

  • Shanghai Renji Hospital

    Shanghai, China

  • Fourth Military Medical University Hospital

    Xijing, China

  • Wroclaw Medical University

    Wroclaw, Poland

  • County Hospital Helsingborg

    Helsingborg, Sweden

  • County Hospital, Kalmar

    Kalmar, Sweden

  • Linköping University Hospital

    Linköping, Sweden

  • Skane University Hospital, Lund

    Lund, Sweden

  • Örebro University Hospital

    Örebro, Sweden

  • Skellefteå Hospital

    Skellefteå, Sweden

  • County Hospital Sundsvall-Härnösand

    Sundsvall, Sweden

  • University Hospital, Uppsala

    Uppsala, Sweden

  • Västerås Hospital

    Västerås, Sweden

  • Center for Clinical Research

    Västerås, Sweden

  • Växjö Hospital

    Vaxjo, Sweden

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.